Compare Davita Inc (DVA) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Kraft Heinz Co — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Kraft Heinz Co trades at $22.51 (market cap $26.06B). The key difference: Kraft Heinz Co is far larger — about 2.3× Davita Inc's market cap, and Kraft Heinz Co pays a 7.28% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Kraft Heinz Co for 129 Days on average.
| DVA | KHC | |
|---|---|---|
Market Cap | $11.28B | $26.06B |
Volume | 650,294 | 15,326,651 |
Sector | Health | Consumer Staples |
52-Week High | $240.96 | $27.62 |
52-Week Low | $103.87 | $21.21 |
Typical Hold Time | 113 Days | 129 Days |
Enterprise Value | $24.00B | $42.38B |
Dividend Yield | — | 7.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
Kraft Heinz (KHC) trades at $22.48, up 2.04% today, with a bearish technical signal but recent earnings beats. The stock shows a low P/E of 13.04 and P/B of 0.72, yet profitability is weak with a -13.64% net margin. Cash flow improved to $1.46B in 2025, but a $5.85B net loss and high debt of $19.22B pose challenges. News highlights dividend stability and brand revitalization efforts, such as new Philadelphia cream cheese flavors.
Outlook remains cautious; the stock offers value with a dividend yield near 6%, but turnaround success is critical. Risks include sustained volume declines and debt servicing. Analysts are mixed with a $23.78 consensus target, suggesting limited upside. Institutional interest exists, but weak fundamentals warrant careful monitoring for recovery signs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
